HYPERSNAP
Commercial- Indications
- Brain tumors, Colorectal surgery, Neurosurgery
Company intelligence / Profile preview
Hypervision Surgical has developed a real-time hyperspectral imaging-based medical device for intraoperative use. Their HYPERSNAP® system has achieved UKCA regulatory clearance, making it the first such device cleared in the UK. The company’s AI-powered platform enables dye-free visualization and quantitative tissue analysis during surgery, aiming to improve precision and patient outcomes across multiple surgical fields. Clinical results are early but promising; commercial deployment has begun in select markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hypervision Surgical.